<VariationArchive RecordType="classified" VariationID="4533" VariationName="NM_001122955.4(BSCL2):c.507_508del (p.Tyr170fs)" VariationType="Deletion" Accession="VCV000004533" Version="3" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-11-11" DateCreated="2015-10-26" MostRecentSubmission="2023-07-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19572" VariationID="4533">
      <GeneList>
        <Gene Symbol="BSCL2" FullName="BSCL2 lipid droplet biogenesis associated, seipin" GeneID="26580" HGNC_ID="HGNC:15832" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11q12.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="62690262" stop="62709537" display_start="62690262" display_stop="62709537" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="62457733" stop="62477090" display_start="62457733" display_stop="62477090" Strand="-" />
          </Location>
          <OMIM>606158</OMIM>
        </Gene>
        <Gene Symbol="HNRNPUL2-BSCL2" FullName="HNRNPUL2-BSCL2 readthrough (NMD candidate)" GeneID="100534595" HGNC_ID="HGNC:49189" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11q12.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="62690262" stop="62727384" display_start="62690262" display_stop="62727384" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_001122955.4(BSCL2):c.507_508del (p.Tyr170fs)</Name>
      <CanonicalSPDI>NC_000011.10:62694689:AC:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q12.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="62694690" stop="62694691" display_start="62694690" display_stop="62694691" variantLength="2" positionVCF="62694689" referenceAlleleVCF="TAC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="62462162" stop="62462163" display_start="62462162" display_stop="62462163" variantLength="2" positionVCF="62462161" referenceAlleleVCF="TAC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>Y170fs</ProteinChange>
      <ProteinChange>Y106fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_235" sequenceAccession="LRG_235">
            <Expression>LRG_235:g.19884_19885del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_235t2" sequenceAccession="LRG_235t2">
            <Expression>LRG_235t2:c.315_316del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_235p2" sequenceAccession="LRG_235p2" change="p.Tyr106fs">
            <Expression>LRG_235p2:p.Tyr106fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032667.6" sequenceAccession="NM_032667" sequenceVersion="6" change="c.315_316delGT">
            <Expression>NM_032667.6:c.315_316delGT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.62694690_62694691del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.62694690_62694691del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.62462162_62462163del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.62462162_62462163del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008461.1" sequenceAccession="NG_008461" sequenceVersion="1" change="g.19884_19885del">
            <Expression>NG_008461.1:g.19884_19885del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033077.1" sequenceAccession="NG_033077" sequenceVersion="1" change="g.209_210del">
            <Expression>NG_033077.1:g.209_210del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_037946.1" sequenceAccession="NR_037946" sequenceVersion="1" change="n.3027_3028del">
            <Expression>NR_037946.1:n.3027_3028del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001122955.4" sequenceAccession="NM_001122955" sequenceVersion="4" change="c.507_508del" MANESelect="true">
            <Expression>NM_001122955.4:c.507_508del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001116427.1" sequenceAccession="NP_001116427" sequenceVersion="1" change="p.Tyr170fs">
            <Expression>NP_001116427.1:p.Tyr170fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130702.2" sequenceAccession="NM_001130702" sequenceVersion="2" change="c.315_316del">
            <Expression>NM_001130702.2:c.315_316del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124174.2" sequenceAccession="NP_001124174" sequenceVersion="2" change="p.Tyr106fs">
            <Expression>NP_001124174.2:p.Tyr106fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386027.1" sequenceAccession="NM_001386027" sequenceVersion="1" change="c.507_508del">
            <Expression>NM_001386027.1:c.507_508del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001372956.1" sequenceAccession="NP_001372956" sequenceVersion="1" change="p.Tyr170fs">
            <Expression>NP_001372956.1:p.Tyr170fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386028.1" sequenceAccession="NM_001386028" sequenceVersion="1" change="c.507_508del">
            <Expression>NM_001386028.1:c.507_508del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001372957.1" sequenceAccession="NP_001372957" sequenceVersion="1" change="p.Tyr170fs">
            <Expression>NP_001372957.1:p.Tyr170fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032667.6" sequenceAccession="NM_032667" sequenceVersion="6" change="c.315_316del">
            <Expression>NM_032667.6:c.315_316del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_116056.3" sequenceAccession="NP_116056" sequenceVersion="3" change="p.Tyr106fs">
            <Expression>NP_116056.3:p.Tyr106fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA277920" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606158.0003" DB="OMIM" />
        <XRef Type="rs" ID="786205070" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001122955.4(BSCL2):c.507_508del (p.Tyr170fs) AND Congenital generalized lipodystrophy type 2" Accession="RCV000004791" Version="5">
        <ClassifiedConditionList TraitSetID="1248">
          <ClassifiedCondition DB="MedGen" ID="C1720863">Congenital generalized lipodystrophy type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001122955.4(BSCL2):c.507_508del (p.Tyr170fs) AND Berardinelli-Seip congenital lipodystrophy" Accession="RCV003311637" Version="1">
        <ClassifiedConditionList TraitSetID="50960">
          <ClassifiedCondition DB="MedGen" ID="CN262437">Berardinelli-Seip congenital lipodystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2016-01-06" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-01-06" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-10-26" MostRecentSubmission="2023-07-16">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">11479539</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19226263</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2023-07-11">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="50960" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="42980" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Berardinelli-Seip congenital lipodystrophy</ElementValue>
                <XRef ID="GPDx_BSCL_BSCL2_001" DB="GenePathDx, GenePath diagnostics" />
                <XRef ID="MONDO:0018883" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BSCL</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13388" />
                <XRef ID="13388" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301391</ID>
                <ID Source="BookShelf">NBK1212</ID>
              </Citation>
              <XRef ID="528" DB="Orphanet" />
              <XRef ID="CN262437" DB="MedGen" />
              <XRef ID="MONDO:0018883" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1248" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2558" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SEIP SYNDROME</ElementValue>
                <XRef Type="MIM" ID="269700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital generalized lipodystrophy type 2</ElementValue>
                <XRef ID="Congenital+Generalized+Lipodystrophy+Type+2/1830" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010020" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BERARDINELLI SYNDROME</ElementValue>
                <XRef Type="MIM" ID="269700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BRUNZELL SYNDROME, BSCL2-RELATED</ElementValue>
                <XRef Type="MIM" ID="269700" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CGL2</ElementValue>
                <XRef Type="MIM" ID="269700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Berardinelli-Seip congenital lipodystrophy (BSCL) is usually diagnosed at birth or soon thereafter. Because of the absence of functional adipocytes, lipid is stored in other tissues, including muscle and liver. Affected individuals develop insulin resistance and approximately 25%-35% develop diabetes mellitus between ages 15 and 20 years. Hepatomegaly secondary to hepatic steatosis and skeletal muscle hypertrophy occur in all affected individuals. Hypertrophic cardiomyopathy is reported in 20%-25% of affected individuals and is a significant cause of morbidity from cardiac failure and early mortality.</Attribute>
                <XRef ID="NBK1212" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10212" />
                <XRef ID="10212" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301391</ID>
                <ID Source="BookShelf">NBK1212</ID>
              </Citation>
              <XRef ID="528" DB="Orphanet" />
              <XRef ID="C1720863" DB="MedGen" />
              <XRef ID="MONDO:0010020" DB="MONDO" />
              <XRef Type="MIM" ID="269700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="24967" SubmissionDate="2015-10-23" DateLastUpdated="2015-10-26" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606158.0003_LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2" title="BSCL2, 2-BP DEL, 659GT_LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2" />
        <ClinVarAccession Accession="SCV000024967" DateUpdated="2015-10-26" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a French family segregating Berardinelli-Seip congenital lipodystrophy (CGL2; 269700), Magre et al. (2001) identified compound heterozygosity for mutations in the BSCL2 gene: deletion of 2 basepairs (GT) at nucleotide 659, resulting in a frameshift and premature termination at codon 112; and a 258-bp deletion/12-bp insertion in exons 5-6 (606158.0004).</Attribute>
              <Citation>
                <ID Source="PubMed">11479539</ID>
              </Citation>
              <XRef DB="OMIM" ID="269700" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BSCL2" />
          </GeneList>
          <Name>BSCL2, 2-BP DEL, 659GT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 659GT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606158.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7508475" SubmissionDate="2023-06-02" DateLastUpdated="2023-07-16" DateCreated="2023-07-16">
        <ClinVarSubmissionID localKey="NM_032667.6:c.315_316delGT|Orphanet:528" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004011972" DateUpdated="2023-07-16" DateCreated="2023-07-16" Type="SCV" Version="1" SubmitterName="Inherited Neuropathy Consortium Ii, University Of Miami" OrgID="508951" OrganizationCategory="consortium" OrgAbbreviation="Lab-SZU" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-01-06">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19226263</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BSCL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_032667.6:c.315_316delGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA528" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13361505</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7508475" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA528" MappingRef="Orphanet">
        <MedGen CUI="CN262437" Name="Berardinelli-Seip congenital lipodystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="24967" TraitType="Disease" MappingType="Name" MappingValue="LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2" MappingRef="Preferred">
        <MedGen CUI="C1720863" Name="Congenital generalized lipodystrophy type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

